These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25904061)

  • 1. Platelets from flowing blood attach to the inflammatory chemokine CXCL16 expressed in the endothelium of the human vessel wall.
    Meyer Dos Santos S; Blankenbach K; Scholich K; Dörr A; Monsefi N; Keese M; Linke B; Deckmyn H; Nelson K; Harder S
    Thromb Haemost; 2015 Aug; 114(2):297-312. PubMed ID: 25904061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inflammatory chemokine CXC motif ligand 16 triggers platelet activation and adhesion via CXC motif receptor 6-dependent phosphatidylinositide 3-kinase/Akt signaling.
    Borst O; Münzer P; Gatidis S; Schmidt EM; Schönberger T; Schmid E; Towhid ST; Stellos K; Seizer P; May AE; Lang F; Gawaz M
    Circ Res; 2012 Oct; 111(10):1297-307. PubMed ID: 22927331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL16/CXCR6-mediated adhesion of human peripheral blood mononuclear cells to inflamed endothelium.
    Linke B; Meyer Dos Santos S; Picard-Willems B; Keese M; Harder S; Geisslinger G; Scholich K
    Cytokine; 2019 Oct; 122():154081. PubMed ID: 28647282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c7E3 Fab inhibits low shear flow modulated platelet adhesion to endothelium and surface-absorbed fibrinogen by blocking platelet GP IIb/IIIa as well as endothelial vitronectin receptor--results from patients with acute myocardial infarction and healthy controls.
    Reininger AJ; Agneskirchner J; Bode PA; Spannagl M; Wurzinger LJ
    Thromb Haemost; 2000 Feb; 83(2):217-23. PubMed ID: 10739376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of CXCL16/CXCR6 with carotid atherosclerosis in patients with metabolic syndrome.
    Lv Y; Hou X; Ti Y; Bu P
    Clin Nutr; 2013 Oct; 32(5):849-54. PubMed ID: 23398954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
    Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SR-PSOX at sites predisposed to atherosclerotic lesion formation mediates monocyte-endothelial cell adhesion.
    Hofnagel O; Engel T; Severs NJ; Robenek H; Buers I
    Atherosclerosis; 2011 Aug; 217(2):371-8. PubMed ID: 21612780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions.
    Wuttge DM; Zhou X; Sheikine Y; Wågsäter D; Stemme V; Hedin U; Stemme S; Hansson GK; Sirsjö A
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):750-5. PubMed ID: 14988089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic adhesion of eryptotic erythrocytes to immobilized platelets via platelet phosphatidylserine receptors.
    Walker B; Towhid ST; Schmid E; Hoffmann SM; Abed M; Münzer P; Vogel S; Neis F; Brucker S; Gawaz M; Borst O; Lang F
    Am J Physiol Cell Physiol; 2014 Feb; 306(3):C291-7. PubMed ID: 24284794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eryptotic red blood cell adhesion to vascular endothelium: CXCL16/SR-PSOX, a pathological amplifier. Focus on "Dynamic adhesion of eryptotic erythrocytes to endothelial cells via CXCL16/SR-PSOX".
    Lauf PK
    Am J Physiol Cell Physiol; 2012 Feb; 302(4):C642-3. PubMed ID: 22189557
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor.
    Hoylaerts MF
    Verh K Acad Geneeskd Belg; 1997; 59(3):161-83. PubMed ID: 9490916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet adhesion.
    Packham MA; Mustard JF
    Prog Hemost Thromb; 1984; 7():211-88. PubMed ID: 6397767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL16 haplotypes in patients with human carotid atherosclerosis: preliminary results.
    Zivković M; Djurić T; Stojković L; Jovanović I; Končar I; Davidović L; Veljković N; Alavantić D; Stanković A
    J Atheroscler Thromb; 2015; 22(1):10-20. PubMed ID: 25142184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism and functional impact of CD40 ligand-induced von Willebrand factor release from endothelial cells.
    Möller K; Adolph O; Grünow J; Elrod J; Popa M; Ghosh S; Schwarz M; Schwale C; Grässle S; Huck V; Bruehl C; Wieland T; Schneider SW; Nobiling R; Wagner AH; Hecker M
    Thromb Haemost; 2015 May; 113(5):1095-108. PubMed ID: 25608503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL16 in kidney and cardiovascular injury.
    Izquierdo MC; Martin-Cleary C; Fernandez-Fernandez B; Elewa U; Sanchez-Niño MD; Carrero JJ; Ortiz A
    Cytokine Growth Factor Rev; 2014 Jun; 25(3):317-25. PubMed ID: 24861945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding.
    Kleinschnitz C; Pozgajova M; Pham M; Bendszus M; Nieswandt B; Stoll G
    Circulation; 2007 May; 115(17):2323-30. PubMed ID: 17438148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells.
    Shimaoka T; Nakayama T; Fukumoto N; Kume N; Takahashi S; Yamaguchi J; Minami M; Hayashida K; Kita T; Ohsumi J; Yoshie O; Yonehara S
    J Leukoc Biol; 2004 Feb; 75(2):267-74. PubMed ID: 14634054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet SR-PSOX/CXCL16-CXCR6 Axis Influences Thrombotic Propensity and Prognosis in Coronary Artery Disease.
    Guan T; Emschermann F; Schories C; Groga-Bada P; Martus P; Borst O; Gawaz M; Geisler T; Rath D; Chatterjee M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperreactivity of junctional adhesion molecule A-deficient platelets accelerates atherosclerosis in hyperlipidemic mice.
    Karshovska E; Zhao Z; Blanchet X; Schmitt MM; Bidzhekov K; Soehnlein O; von Hundelshausen P; Mattheij NJ; Cosemans JM; Megens RT; Koeppel TA; Schober A; Hackeng TM; Weber C; Koenen RR
    Circ Res; 2015 Feb; 116(4):587-99. PubMed ID: 25472975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the CXCL16/CXCR6 Pathway by Inflammation Contributes to Atherosclerosis in Patients with End-stage Renal Disease.
    Hu ZB; Chen Y; Gong YX; Gao M; Zhang Y; Wang GH; Tang RN; Liu H; Liu BC; Ma KL
    Int J Med Sci; 2016; 13(11):858-867. PubMed ID: 27877078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.